| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K85133207 |
| PharmacoGx | BRD-K85133207 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XYLB | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | PLS3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | MAGEA10 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | NCR2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AC027682.1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | ZNF66 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | PRRC2A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | CD7 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | UPF3A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TSNAX-DISC1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
